Graham Smith
www.cyberleagle.com
Graham is a partner in international law firm Bird & Bird LLP. He is based in London and is one of the UK's leading cyberlaw experts, with a practice encompassing advisory and contentious work in the internet, IT and intellectual property fields.
On 20th January 2018, Ascertia is launching the SigningHub Winter ’18 release (v7.4). This release is all about improved speed and usability. It ensures that all the new and exciting features deliver you, our customers and partners, a great experience - thank you for your feedback!
In this blog, we discuss how SigningHub implements HIPAA-compliant eSignatures.
What is HIPAA?
HIPAA (Health Insurance Portability and Accountability Act of 1996) is a United States legislation that provides data privacy and security provisions for safeguarding medical information.
In this blog, we discuss the international document regulations you need to know when making a digital transformation.
60+ countries have standards and legal frameworks for eSignatures and digital transactions. This list grows each year, which makes it challenging for international organisations to deliver compliant business processes.
Esignatures are being extensively adopted across most industries to improve security, reduce the use of paper, accelerate approval processes and enhance workflows. In our latest eBook, we identify how different industries benefit from eSignatures.
On 9th September 2017, Ascertia launched the SigningHub Autumn ’17 release (v7.3). This release includes powerful performance enhancements, additional API calls and expanded user functionality to enable the ultimate signing experience!
In this blog, we examine whether you have sole control of your eSignature. There are many types of electronic signatures but some of the most commonly used in business are Advanced Electronic Signatures as they are secure, identifiable and in some cases mandated by legislation or policy.
In our latest industry-specific blog, we're focusing on how the pharmaceutical industry can ensure FDA 21 CFR part 11 compliance with eSignatures.
Some of the world’s strictest regulations are found in the pharmaceutical industry and companies in this sector will have extensive processes and policies to maintain data security. This applies to every department within an organisation - from robust IT systems, to secure solutions used to approve documentation electronically.
This blog discusses how your business can comply with the General Data Protection Regulation (GDPR).
In B2C businesses, customer sentiment is often a main driver for change. In this blog, we examine how consumer confidence is driving eSignature adoption in businesses.
Choosing the right type of e-signature
for your business
